Emerging Treatment for SCLC - Leading Developments & Current Questions in Lung Cancer

Cancer Photo

4 months 17 Views
For this year's post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center, and Founder and President of GRACE, Christine Lovly, Associate Professor of Medicine, Division of Hematology-Oncology, and Dr. Alfredo Addeo, Medical Oncologist, department of Oncology at the University Hospital of Geneva (HUG), discuss the most current and emerging treatment information recently presented at ASCO.

Drs. West, Lovly, and Addeo review key information from 2023 ASCO on lung cancer developments, including the results of several trials.

In this video, Drs. West, Lovly, and Addeo discuss whether adding a PARP inhibitor is beneficial to patients with small cell lung cancer (SCLC).

For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.

Sound Used: Once Again (BenSound.com)
License #: 2LN6RROJA08RATWY